Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
出版年份 2021 全文链接
标题
Liver fibrosis in patients with metabolic associated fatty liver disease is a risk factor for adverse outcomes in COVID-19
作者
关键词
liver steatosis, computed tomography, SARS-CoV-2, prognosis
出版物
DIGESTIVE AND LIVER DISEASE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-02-03
DOI
10.1016/j.dld.2021.01.019
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Complications, morbidity and mortality of nonalcoholic fatty liver disease
- (2020) Alessandro Mantovani et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2020) Sadaf G Sepanlou et al. Lancet Gastroenterology & Hepatology
- Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores
- (2020) Giovanni Targher et al. GUT
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico
- (2020) Omar Yaxmehen Bello-Chavolla et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
- (2020) Dong Ji et al. JOURNAL OF HEPATOLOGY
- Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
- (2020) Ya Gao et al. JOURNAL OF INFECTION
- Predictors of mortality in hospitalized COVID‐19 patients: A systematic review and meta‐analysis
- (2020) Wenjie Tian et al. JOURNAL OF MEDICAL VIROLOGY
- Liver injury in COVID-19: The current evidence
- (2020) Saleh A Alqahtani et al. United European Gastroenterology Journal
- Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
- (2020) Abdulzahra Hussain et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States
- (2017) Michael H. Le et al. PLoS One
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More